SCHEMBL23927546

SCHEMBL23927546

CC(C)(C)c1ccc(Nc2ccc3c(c2)C(C)(C)CCC3(C)C)c(-c2ccc3c(c2)C(C)(C)CCC3(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARA P10276 13/20 0.39
▸ RARB P10826 12/20 0.39
▸ RARG P13631 11/20 0.39
▸ CYP26A1 O43174 6/20 0.39
▸ RXRA P19793 4/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ PGR P06401 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ TBXA2R P21731 1/20 0.39
▸ BLVRB P30043 1/20 0.39
▸ RXRB P28702 1/20 0.37
▸ JAK2 O60674 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ CYP26B1 Q9NR63 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23444328 0.95 RARA (0.39) RARARARBRARGCYP26A1RXRA
SCHEMBL22934074 0.90 CYP26A1 (0.40) RARARARBRARGCYP26A1RXRA
SCHEMBL25810318 0.88 JAK2 (0.34) RARARARBRARGCYP26A1RXRA
SCHEMBL23450915 0.88 RARB (0.40) RARARARBRARGCYP26A1RXRA
SCHEMBL23445678 0.86 RARA (0.40) RARARARBRARGCYP26A1RXRA
SCHEMBL23439324 0.84 CYP26A1 (0.42) RARARARBRARGCYP26A1RXRA
SCHEMBL24772649 0.82 CYP26A1 (0.36) RARARARBRARGCYP26A1RXRA
SCHEMBL29986780 0.80 CYP26A1 (0.39) RARARARBRARGCYP26A1RXRA
SCHEMBL23116372 0.80 CYP26A1 (0.47) RARARARBRARGCYP26A1RXRA
SCHEMBL29366406 0.80 CYP26A1 (0.47) RARARARBRARGCYP26A1RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559467-B2 Organic light emitting device LG CHEM, LTD. (KR) 2026-02-24 — — US disclosed
US-20230084250-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-03-16 — — US disclosed
US-20230002420-A1 ORGANIC LIGHT-EMITTING ELEMENT LG CHEM, LTD. (KR) 2023-01-05 — — US disclosed
US-20230002420-A1 ORGANIC LIGHT-EMITTING ELEMENT LG CHEM, LTD. (KR) 2023-01-05 — — US disclosed
US-20220399501-A1 ORGANIC LIGHT-EMITTING ELEMENT LG CHEM, LTD. (KR) 2022-12-15 — — US disclosed
CN-113906581-A Organic light emitting element 株式会社LG化学 2022-01-07 — — CN disclosed
CN-113875033-A Organic light emitting device 株式会社LG化学 2021-12-31 — — CN disclosed
CN-113646915-A Organic light emitting device 株式会社LG化学 2021-11-12 — — CN disclosed
EP-3901158-A2 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG Chem, Ltd. (KR) 2021-10-27 — — EP disclosed
CN-113396151-A Polycyclic compound and organic light-emitting element comprising same 株式会社LG化学 2021-09-14 — — CN disclosed
CN-113228335-A Organic light emitting device 株式会社LG化学 2021-08-06 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002420-A1 ORGANIC LIGHT-EMITTING ELEMENT CYBA, CRY1, CYP1A1 RARA 895/4885RARB 1302/4885RARG 1268/4885
US-20220399501-A1 ORGANIC LIGHT-EMITTING ELEMENT CYP1A1, AHR, CYP1B1 RARA 1347/4885RARB 1960/4885RARG 1839/4885
US-20230084250-A1 ORGANIC LIGHT EMITTING DEVICE CRY1, CRY2, PER2 RARA 486/4885RARB 832/4885RARG 639/4885
US-12559467-B2 Organic light emitting device CRY1, RPS24, ARL1 RARA 449/4885RARB 625/4885RARG 507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback